STUDY TO SEE THE EFFECT OF ERECTOR SPINAE PLANE BLOCK AND QUADRATUS LUMBORUM BLOCK FOR PAIN RELEIF IN PATIENTS UNDERGOING RENAL TRANSPLANT OPERATION

EFFICACY OF ERECTOR SPINAE PLANE BLOCK AND QUADRATUS LUMBORUM BLOCK FOR PERIOPERATIVE ANALGESIA IN PATIENTS SCHEDULED FOR RENAL TRANSPLANTATION - A SINGLE BLINDED RANDOMIZED CONTROLLED STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021219

Enrollment

Registered

2019-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Erector Spinae Plane Block: 30ml of 0.375% Ropivacaine injection is utilised for USG guided ipsilateral Erector spinae plane block Intervention2: Quadratus lumborum block: 30ml of 0.375

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing renal transplantation under General Anesthesia

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate 2. Known hypersensitivity to local anaesthetic drug 3. Patient having infection at site of block 4. Patient having spinal Deformity and previous history 5. Patients on anti coagulants 6. Patients with untreated psychiatric illness

Design outcomes

Primary

Measure	Time frame
Compare perioperative fentanyl consumption between Erector spinae plane block group, Quadratus lumborum block group and control group in patients undergoing renal transplantation over a period of 24 hours after surgeryTimepoint: Intraoperative time plus postoperative follow up of 24 hours	—

Secondary

Measure	Time frame
Pain scores using numerical rating scale, time for first rescue analgesic and incidence of postoperative nausea and vomiting between Erector spinae plane block group, Quadratus lumborum block group and control group in patients undergoing renal transplantation surgery over a period of 24 hoursTimepoint: Intraoperative time plus postoperative follow up of 24 hours	—

Countries

India

Contacts

Public ContactDr Virender Kumar Mohan

All India Institute of Medical Sciences

dr_vkmohan@yahoo.com9891557705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026